[go: up one dir, main page]

HK40006685A - Dihydropyranopyrimidines for the treatment of viral infections - Google Patents

Dihydropyranopyrimidines for the treatment of viral infections Download PDF

Info

Publication number
HK40006685A
HK40006685A HK19130267.8A HK19130267A HK40006685A HK 40006685 A HK40006685 A HK 40006685A HK 19130267 A HK19130267 A HK 19130267A HK 40006685 A HK40006685 A HK 40006685A
Authority
HK
Hong Kong
Prior art keywords
dihydropyranopyrimidines
treatment
viral infections
infections
viral
Prior art date
Application number
HK19130267.8A
Other languages
Chinese (zh)
Inventor
Tim Hugo Maria Jonckers
Pierre Jean-Marie Bernard Raboisson
Jérôme Émile Georges GUILLEMONT
David Craig Mc Gowan
Werner Constant Johan Embrechts
Ludwig Paul Cooymans
Laurent CALMUS
Original Assignee
Janssen Sciences Ireland Unlimited Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Company filed Critical Janssen Sciences Ireland Unlimited Company
Publication of HK40006685A publication Critical patent/HK40006685A/en

Links

HK19130267.8A 2016-07-01 2017-06-30 Dihydropyranopyrimidines for the treatment of viral infections HK40006685A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16177401 2016-07-01

Publications (1)

Publication Number Publication Date
HK40006685A true HK40006685A (en) 2020-05-22

Family

ID=

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
EP3102225A4 (en) Combination therapy for treatment of hbv infections
EP3160405A4 (en) Treatment of the ear
EP3157565A4 (en) Treatment of polybacterials infections
SI3697405T1 (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
EP3490561A4 (en) Combinations for the treatment of cancer
EP3166615A4 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections
IL256327B (en) Pharmaceuticals for treatment of viral infections of the eye
EP3503887A4 (en) Combinations for the treatment of cancer
EP3400007A4 (en) Orthomyxo-like virus of tilapia
IL258137B1 (en) Means for the treatment of hiv
EP3426671A4 (en) Compounds and compositions for the treatment of infections
EP3256124A4 (en) Cenicriviroc for the treatment of fibrosis
SI3471732T1 (en) Liposomes for the treatment of viral infections
EP3650015A4 (en) Combined medicinal preparation for treating viral infections
EP3448377A4 (en) Methods for the treatment of infection
EP3236986A4 (en) Methods for treating immune-mediated viral infections
EP3122190A4 (en) Compositions and related methods for treating and preventing viral and retroviral infections
EP3511408A4 (en) Composition for the treatment or prophylaxis of viral infections
EP3148538A4 (en) Cenicriviroc for the treatment of hiv-2 infection
HK40006685A (en) Dihydropyranopyrimidines for the treatment of viral infections
HK40107870A (en) Esketamine for the treatment of depression
HK40091518A (en) Composition for the treatment of veisalgia
HK40095812A (en) Inhibitors of c5a for the treatment of viral pneumonia